IMMUNICUM
Live / Registered — International registration cancelled — extension of protection cancelled (as of 12 Aug 2023)
What this means for you
Registered since 10 Jun 2014. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79136831
- Registration number
- 4545834
- Mark type
- Stylized text
- Filed
- 13 Aug 2013
- Published for opposition
- 25 Mar 2014
- Registered
- 10 Jun 2014
- Attorney of record
- Mary L. Shapiro
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; medicines for human purposes for the treatment of cancer; anti-cancer drugs; immunotherapeutic substances for treatment of cancer, namely, immunotherapeutic medications for the treatment of cancer, immunotherapeutic pharmaceutical preparations for the treatment of cancer
- Class 042 — Scientific and technological services: Research on the subject of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals
Owner
- Mendus AB, SE
- Immunicum AB, SE
- Immunicum AB, SE
Prosecution history
- 10 Mar 2024 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 10 Mar 2024 — DEATH OF INTERNATIONAL REGISTRATION
- 10 Jun 2023 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 01 Jan 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Jan 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 15 May 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 04 Sept 2020 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 04 Sept 2020 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 01 Sept 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Jun 2020 — TEAS SECTION 71 & 15 RECEIVED
- 10 Jun 2019 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 19 Oct 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Nov 2014 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 05 Nov 2014 — FINAL DISPOSITION NOTICE SENT TO IB
- 05 Nov 2014 — FINAL DISPOSITION PROCESSED